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Taurine is protective against oxidative stress during cold
ischemia in the rat kidney
Rüveyda İrem DEMİRCİOĞLU, Burhanettin USTA, Hüseyin SERT, Bünyamin MUSLU,
Muhammet GÖZDEMİR

Aim: Recent studies in rats have shown that taurine can prevent oxidative changes induced in renal tissue by ischemia
and reperfusion. The aim of the present study was to investigate whether taurine can prevent oxidative changes that
occur in the renal tissue during a long period of cold ischemia.
Materials and methods: Oxidative changes were evaluated histologically and biochemically in kidneys from a total
of 40 rats, which were assigned to 1 of 4 groups of 10 rats each: control group (no taurine given, kidneys evaluated
immediately after removal), taurine group (as in the control group, except that taurine was given orally at a dose of 150
mg/kg per day for 3 days preceding kidney removal), ischemia group (no taurine given, kidneys evaluated after 72 h of
ischemia at 4 °C in University of Wisconsin solution), and taurine plus ischemia group (as in the taurine group, except
that kidneys subsequently underwent cold ischemia as in the ischemia group).
Results: Compared to the ischemia group, the taurine plus ischemia group showed significantly lower levels of
malondialdehyde and significantly higher activities of copper and zinc dependent superoxide dismutase, catalase, and
glutathione peroxidase.
Conclusion: Orally administered taurine appears to ameliorate the oxidative stress that occurs in kidneys during cold
ischemia. Compared to the ischemia group, the taurine plus ischemia group had significantly less tubular necrosis, and
glomerular and epithelial injury.
Key words: Antioxidants, ischemia, kidney, taurine, transplantation

Taurinin sıçan böbreğinde soğuk iskemi sırasında oksidatif strese karşı koruyucu
etkisi
Amaç: Ratlarda yapılan son çalışmalar taurinin böbrek dokusunda iskemi ve reperfüzyon ile indüklenen oksidatif
değişiklikleri önleyebileceğini göstermiştir. Bu çalışmanın amacı, taurinin böbrek dokusunda uzun süren soğuk iskemi
döneminde oksidatif değişiklik oluşmasına etkisini araştırmaktır.
Yöntem ve gereç: Böbreklerde oksidatif değişikliklerin histolojik ve biyokimyasal olarak değerlendirildiği 40 sıçan 4 eşit
gruba ayrıldı: Kontrol grubu (taurin verilmedi, böbrek hemen alındıktan sonra değerlendirildi), taurin grubu (böbrek
alınmadan önce taurin 150 mg/kg/gün dozunda 3 gün süreyle oral olarak verildi), iskemi grubu (taurin verilmedi,
nefrektomi materyalli UW solüsyonu içerisinde + 4 °C’de 72 saat tutulduktan sonra histopatolojik ve biyokimyasal
inceleme için örnekleme yapıldı), taurin artı iskemi grubu (iskemi grubunda yapılanlara ilave olarak böbrek alınmadan
önce taurin 150 mg/kg/gün dozunda 3 gün süreyle oral olarak verildi).
Bulgular: İskemi grubu, taurin artı iskemi grubu ile karşılaştırıldığında malondialdehit anlamlı olarak düşük seviyelerde
gözlenirken, süperoksit dismutaz, katalaz ve glutatyon peroksidaz ise anlamlı olarak yüksek seviyelede idi. İskemi grubu,
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taurin artı iskemi grubu ile karşılaştırıldığında anlamlı derecede daha az tubuler nekroz, glomerüler ve epitelyal hasar
vardı.
Sonuç: Daha önceden oral yoldan uygulanan taurinin böbreklerde soğuk iskemi sırasında ortaya çıkan oksidatif stresi
iyileştirdiği görülüyor.
Anahtar sözcükler: Antioksidan, iskemi, böbrek, taurin, transplantasyon

Introduction
Ischemia is a feature of organ transplantation. In
mammalian kidneys, ischemia results in a wide range
of physiologic changes, including the generation of
reactive species in a process known as oxidative
stress (1,2). The reactive species important in this
setting appear to include oxygen free radicals, such
as superoxide and hydroxyl, and reactive oxygen
species, such as hydrogen peroxide (2,3). These
molecules can induce complex cascades of pathologic
changes involving cellular lipids, proteins, nucleic
acids, and other molecules (4,5). Collectively, these
events are known as oxidative stress (5). Prevention
of oxidative changes with antioxidant substances has
been explored in many experimental studies of tissue
ischemia; however, most studies have focused on the
oxidative damage resulting from a combination of
ischemia and reperfusion. Recent studies in rats have
shown that taurine can prevent oxidative changes
induced in renal tissue by ischemia and reperfusion
for a short period of cold ischemia (6-8). The aim of
the present study was to investigate whether taurine
can prevent oxidative changes that occur in renal
tissue during a long period of cold ischemia.
Materials and methods
After the study design was approved by our
institution’s ethics committee, 40 adult Wistar albino
rats (male, 220-240 g) were randomly assigned
to 1 of 4 groups of 10 rats each: control, taurine,
ischemia, and taurine plus ischemia. Throughout
the experimental part of the study, all rats were fed
standard laboratory food and water and were kept in
an environment provided with 12 h light/dark cycles,
at 25 ± 1 °C with 30% humidity. All experiments
were performed in accordance with the ‘Principles
of Laboratory Animal Care’ NIH publication Vol 25,
No. 28 revised 1996. Procedures for the groups were
as follows.
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Control group: The rats were observed for 3
days under laboratory conditions. On day 3, left
kidneys were removed and prepared immediately for
histological and biochemical evaluation.
Taurine group: Rats in this group received a
single oral dose of taurine (Department of Pharmacy,
Ruprecht-Karls University, Heidelberg, Germany)
150 mg/kg per day for 3 days (9). The taurine was
given via oral gavage.
Ischemia group: Kidneys in this group were
placed in University of Wisconsin (UW) solution
maintained at 4 °C for 72 h before histological and
biochemical evaluation.
Taurine plus ischemia group: After the rats
were given taurine (150 mg/kg per day) for 3 days,
left kidneys were removed and they were placed
in UW solution maintained at 4 °C for 72 h before
histological and biochemical evaluation.
Nephrectomy was performed as follows.
Anesthesia was provided with a combination of
intramuscular ketamine HCl (100 mg/kg) and
xylazine HCl (10 mg/kg). The abdominal region was
shaved and the rat was fastened, in a supine position,
to the operating table. Body temperature was
maintained at 37.5 °C with a heating pad placed under
the rat. For anticoagulation, 10 IU/kg heparin was
given intravenously via the caudal vein. After a wait
of 3 min, the abdomen was cleaned with povidoneiodine solution and a midline incision was made.
The left kidney was reached in the retroperitoneal
space. The renal artery, renal vein, and ureter were
identified and clamped, and were then tied with silk
suture and transected.
UW solution (3 mL, 4 °C) was injected into the
renal artery at a pressure of 100 cm H2O (Medrad
auto-injector, Mark V ProVis, USA), and the solution
was permitted to flow from the renal vein. The renal
capsule was removed, and the kidney was bisected
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longitudinally with a scalpel to provide specimens for
the histological and biochemical evaluations. In the
ischemia group and the taurine plus ischemia group,
the kidneys were kept in UW solution at 4 °C for 72 h
before histological and biochemical evaluations.
Specimens for histological evaluation were
fixed in 10% formalin and were placed in paraffin
blocks, from which 5 μm slices were made. These
were stained with hematoxylin-eosin, and were
evaluated by a pathologist blinded to the sources
of the specimens. The evaluation was made at 200×
magnification, in 30 microscopic fields, according to
the 0-4 scoring system described by Guan et al. (8).
By light microscopy, the following were evaluated:
flattening of tubular epithelium, brush border loss,
cytoplasmic vacuolization, nuclear condensation,
nuclear loss, tubular epithelium debris and casts, and
the presence of atrophic tubular epithelium.
For biochemical evaluation of oxidative stress,
specimens were cooled in liquid nitrogen to –160 °C
and were then wrapped in aluminum foil and stored
at –80 °C until immediately before the evaluation
procedure. Oxidative stress was evaluated in terms
of malondialdehyde (MDA) levels and the activities
of copper and zinc dependent superoxide dismutase
(CuZn-SOD), catalase (CAT), and glutathione
peroxidase (GPx).
Tissue specimens were homogenized in ice-cold
1.15% KCl with a glass homogenizer. Cellular residue
was removed by centrifugation of the homogenates
at 4400 × g for 10 min at 4 °C. The remaining
supernatant was analyzed for MDA content and
activities of CuZn-SOD, CAT, and GPx as follows.
MDA activity in tissue homogenate was
measured by the method of Bulucu et al. (10).
MDA levels were measured through the reaction
of MDA with thiobarbituric acid. The reaction
product was measured spectrophotometrically. A
1,1,3,3-tetramethoxypropane solution was used as
a standard. Tissue MDA levels were expressed as
nmol/g of tissue.
CuZn-SOD activity in tissue homogenate was
measured by the method of Yucel et al. (11). CuZnSOD activity was measured through the addition of
25 μL of supernatant to a buffer solution containing
50 mmol/L 3-(cyclohexylamino)-1-propanesulfonic

acid (CAPS) and 0.094 mmol/L EDTA (pH 10.2),
which was mixed with 850 μL of a substrate solution
containing 0.05 mmol/L xanthine sodium and 0.025
mmol/L
2-(4-iodophenyl)-3-(4-nitrophenol)-5phenyl tetrazolium chloride (INT). To this mixture
was added 125 μL of xanthine oxidase (80 U/mL) and
the increase in absorbance at 505 nm against air was
measured for 3 min. As standards, 25-μL samples of
phosphate buffer at a range of concentrations were
used. CuZn-SOD activity was expressed as U/g of
tissue.
CAT activity measurement: CAT activity in tissue
homogenate was measured at 25 °C by the method
of Aebi (12). Substrate H2O2 decomposition rate was
followed spectrophotometrically at 240 nm for 30 s.
Activity was expressed as KU/g.
GSH-Px activity in tissue homogenate was
measured by the method of Aydın et al. (13). GPx
activity was determined with the use of a reaction
mixture at pH 7.6, containing the following: 50
mmol/L Tris buffer, 1 mmol/L disodium EDTA, 2
mmol/L reduced glutathione, 0.2 mmol/L NADPH,
4 mmol/L sodium azide, and 1000 U glutathione
reductase. To 950 μL of this reaction mixture, 50
μL of supernatant was added and the mixture was
incubated at 37 °C for 5 min. The reaction was
started with the addition of 8.8 mmol/L of hydrogen
peroxide, and the reduction in NADPH absorbance
at 340 nm was followed for 3 min. Enzyme activity
was expressed as U/g of tissue.
Statistical analysis was performed with SPSS
version 13.0 (SPSS Inc., Chicago, IL, USA). Variables
were examined with one-way analysis of variance.
Group comparisons were made via the KruskalWallis test and Mann-Whitney U test. Histological
and biochemical results were obtained as mean
± standard deviation. Statistical significance was
defined as P < 0.05.
Results
Histopathological findings
The findings are summarized in Table 1. In the
control and taurine groups, renal tissue sections had
a normal morphology: tubular necrosis and casts
in the tubules were minimal (Figures 1 and 2). In
845
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Table 1. Histological scores in the 4 groups of rats.

Scores

Control
(n = 10)

Taurine
(n = 10)

Ischemia
(n = 10)

Taurine +
Ischemia (n = 10)

Glomerular injury score

0.1 ± 0.1

0.4 ± 0.1

2.4 ± 0.4*

1.7 ± 0.2 **

Tubular injury score

0.1 ± 0.1

0.3 ± 0.2

2.4 ± 0.6*

2.1 ± 0.3 **

Epithelial injury score

0.1 ± 0.1

0.3 ± 0.1

2.9 ± 0.3*

2.4 ± 0.3 **

* P < 0.05 Ischemia group vs. other groups
** P < 0.05 Taurine + ischemia group vs. the other groups.

Figure 1. In the control group, tubular necrosis and casts in the
tubules were minimal (hematoxylin-eosin, 200×).

Figure 2. In the taurine group, there was minimal tubular
damage, as in the control group (hematoxylin-eosin,
200×).

MDA and antioxidant enzymes

the ischemia group (Figure 3), tubular necrosis and
casts in the tubules were significantly more severe
than in the control group (P < 0.05). Compared to
the ischemia group, the taurine plus ischemia group
(Figure 4) had significantly less tubular necrosis and
casts in the tubules (P < 0.05).

Biochemical findings are summarized in Table 2.
Compared to the control group, the ischemia group
had significantly higher levels of MDA (P < 0.05) and
significantly lower activities of CuZn-SOD, CAT, and
GPx. In terms of these parameters, no significant

Figure 3. In the ischemia group, tubular necrosis and casts
in the tubules were markedly apparent, and were
significantly more severe than in the control group (P
< 0.05) (hematoxylin-eosin, 200×).

Figure 4. In the taurine plus ischemia group, tubular necrosis
and casts in the tubules were significantly less than
in the ischemia group (P < 0.05) (hematoxylin-eosin,
200×).
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Table 2. Oxidative stress parameters in the four groups.
MDA

CuZn-SOD

GPx

CAT

U/g

KU/g

Groups
nmol/g

U/g

Control (n = 10)

14.26 (± 1.02)

93.96 (± 8.45)

18.38 (± 0.92)

4.25 (± 0.42)

Taurine (n = 10)

14.20 (± 1.26)

102.22 (± 10.63)

19.09 (± 2.01)

5.53 (± 1.21)

Ischemia (n = 10)

21.20 (± 3.65)*

64.92 (± 4.98)*

15.47 (± 4.06)*

2.31 (± 0.23)*

Taurine + ischemia
(n = 10)

13.32 (± 0.9)**

113.52 (± 11.56)**

20.29 (± 2.98)**

4.22 (± 1.06)**

MDA: malondialdehyde; CuZn-SOD: superoxide dismutase; CAT: catalase
GPx: glutathione peroxidase
* P < 0.05 Ischemia group vs. control group
** P < 0.05 Taurine + ischemia group vs. ischemia group

differences were found between the control group and
the taurine group. Compared to the ischemia group,
the taurine plus ischemia group had significantly
lower levels of malondialdehyde and significantly
higher activities of CuZn-SOD, CAT, and GPx.
Discussion
Findings of the present study: (i) tissue GSH-Px,
SOD, and CAT levels are significantly higher in the
taurine + ischemia group compared to the ischemia
group; (ii) tissue MDA levels are significantly lower
in the taurine + ischemia group than in the ischemia
group, and (iii) tubular, epithelial and glomerular
injury are significantly better in the taurine +
ischemia group than in the ischemia group.
In the setting of ischemia and reperfusion that
occur during kidney transplantation, this approach
has led to many reports of clear benefits in animal
studies, but clinical applications in humans have
been far fewer. In that study ischemia durations are
low. In this study, we showed that taurine can prevent
oxidative changes, which occur in renal tissue during
cold ischemia, even for a period of up to 72 h.
Prevention of oxidative damage to tissues has been
the aim of many studies, and the general approach
has been to inhibit enzymes that generate reactive
species, or to scavenge the reactive species themselves.
A possible reason for this is the complexity of events

that characterize oxidative damage (5). The rationale
for the present study was to limit the possible
mechanisms of oxidative changes by focusing on
one step in the transplantation process, namely the
period of cold ischemia.
Several animal studies have indicated that oxidative
changes seen after renal ischemia and reperfusion can
be lessened by treatment with taurine (6-8). Michalk et
al. (6) induced transient ischemia in rats by clamping
the renal artery for 60 min. The authors reported
that intravenous administration of taurine at a dose
of 40 mg/kg for 10 min before clamping significantly
lessened the subsequent rise in serum levels of
creatinine and the renal tubular enzymes lactate
dehydrogenase and gamma-glutathione-S-transferase.
These parameters were measured during reperfusion,
at 90 min after the clamp was removed from the renal
artery. In a similar study in rats, Guz et al. (7) clamped
the renal arteries for 40 min, and then at the beginning
of reperfusion they injected taurine into the peritoneal
cavity at a dose of 7.5 mg/kg. After 6 h of reperfusion,
the rats that had received taurine showed significantly
smaller increases in serum creatinine and in serum
and tissue levels of MDA, the latter indicating less
extensive lipid peroxidation. Renal histologic changes
were less extensive in these animals as well, compared
to rats that underwent ischemia and reperfusion
without receiving taurine. The findings of these 2
studies cannot be directly combined with those of the
847
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present study, due to the lack of cold ischemia in the
2 studies and the lack of reperfusion in the present
study. However, the findings of the present study are
consistent with those of the previous 2 in suggesting a
role for taurine in the prevention or reversal of injury
that may occur early in the combined process of renal
ischemia and reperfusion.
In a study that included a period of cold
ischemia, Guan et al. (8) investigated the effects
of taurine given intravenously to rats whose
kidneys were then removed, placed in histidinetryptophan-ketoglutarate solution at 4 °C for 19 h,
and transplanted into other rats that had undergone
bilateral nephrectomy. After the transplanted kidneys
remained 6 h in the recipient rats, serum indicators
of renal function and histological specimens of renal
tissue were evaluated. The authors reported that
taurine significantly decreased blood urea nitrogen,
creatinine, aspartate aminotransferase, and lactate
dehydrogenase in a dose-dependent manner. Tubular
damage was less severe in rats that received taurine,
as was the case in our study. Guan et al. (8) also noted
that taurine pretreatment was associated with greater
expression of superoxide dismutase, and our finding
of increased CuZn-SOD activity is consistent with
this study. Collectively, these findings suggest an
involvement of taurine in multiple cellular events,
including those that might be a direct consequence
of cold ischemia.
Cold ischemia, even when not followed by
reperfusion, has been shown in animal studies to
result in oxidative changes in renal tissue (15-18).
Human renal tubular cells in cold storage have
likewise been found to generate reactive oxygen
species (19).
The mechanisms of renal injury that are active
during cold ischemia are diverse and include ATP
depletion, acidosis, mitochondrial swelling, calcium
influx into the cytosol, iron release, and free radical
generation (20). In a study of rabbit kidneys kept
at 0 °C for 24 or 48 h, Green et al. found that lipid
peroxidation was more extensive when kidneys were
kept in isotonic saline rather than in hypertonic
citrate solution (15). Gower et al. (16), also working
with rabbit kidneys kept at 0 °C for 24 h in isotonic
saline, found that lipid peroxidation in the renal
cortex was predominantly non-specific and iron848

catalyzed, while in the medulla about half of the
detected lipid peroxidation was formed enzymatically
from arachidonic acid by cyclooxygenase. In a
subsequent study, Gower et al. reported that the iron
chelator desferrioxamine, when given intravenously
to the rabbits before the kidneys were removed,
resulted in less lipid peroxidation in the renal cortex
during cold storage. In the same study, intravenous
administration of the cyclooxygenase inhibitor
indomethacin had no effect on lipid peroxidation in
the cortex, but lessened it in the medulla (17). Cotterill
et al. (18) investigated the effect of adding calcium to
the solution in which rabbit kidneys were stored at 0
°C for 24 h, and found a significant increase in lipid
peroxidation when calcium was present. In a study of
human renal tubular cells kept in UW solution at 4
°C for 24, 48, or 72 h, Salahudeen et al. (19) reported
that cold-induced lactate dehydrogenase release, ATP
depletion, DNA damage, and membrane degradation
were suppressed by the antioxidants 2-methyl
aminochroman or deferoxamine.
Taurine, or 2-aminoethanesulfonic acid, due to its
capacity to ameliorate oxidative injury, has frequently
been described as an antioxidant. However, in vitro
taurine has little direct antioxidant activity (21,22).
According to a study designed by Mozaffari et al. (23),
in rats taurine 1% against renal ischemia-reperfusion
injury does not provide a functional improvement.
In fact, the lack of taurine against renal ischemiareperfusion injury may be more useful. This apparent
inconsistency raises the question of how taurine
might influence the events involved in oxidative
damage in vivo. Mitochondrial enzymes have been
implicated in the generation of reactive species (2).
Hansen et al. (24) have hypothesized that taurine
exerts its antioxidative effect by buffering the pH in
the mitochondrial matrix and thereby preventing the
leakage of the reactive compounds. This hypothesis
appears to be consistent with the mitochondrial
swelling and leakage reported by Salahudeen et al. in
their study of cultured human tubular cells that were
kept in cold storage (25).
In this study, we showed that taurine can prevent
oxidative changes that occur in renal tissue during
cold ischemia even for up to 72 h. Because patients can
be delayed in arriving to the hospital, and because in
cadaveric transplantation the period of cold ischemia
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can sometimes be extensive, taurine might truly be
effective in protecting donor kidneys from damage
related to long periods of cold ischemia. However, to
reach this conclusion definitively, more animal and

human studies are needed. Whether such changes
occur in intact kidneys undergoing cold storage or
if taurine can prevent or lessen these changes are
questions for further research.
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